Jim Simons Harmony Biosciences Holdings, Inc. Transaction History

Renaissance Technologies LLC

$62.3 Billion
Q1 2025

A detailed history of Jim Simons (Renaissance Technologies LLC) transactions in Harmony Biosciences Holdings, Inc. stock. As of the latest transaction made, Renaissance Technologies LLC holds 840,371 shares of HRMY stock, worth $29.8 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares

840,371

Previous 568,671 47.78%

Holding current value

$29.8 Million

Previous $19.6 Million 42.54%

% of portfolio

0.04%

Previous 0.03%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 14, 2025	BUY	$32.18 - $40.46 $8.74 Million - $11 Million	271,700 Added 47.78%	840,371 $27.9 Million
Q4 2024 Feb 13, 2025	BUY	$31.86 - $41.49 $2.42 Million - $3.16 Million	76,071 Added 15.44%	568,671 $19.6 Million
Q3 2024 Nov 13, 2024	SELL	$30.0 - $39.95 $3.1 Million - $4.12 Million	-103,200 Reduced 17.32%	492,600 $19.7 Million
Q2 2024 Aug 09, 2024	BUY	$28.81 - $33.01 $6.21 Million - $7.12 Million	215,700 Added 56.75%	595,800 $18 Million
Q1 2024 May 13, 2024	BUY	$29.93 - $35.06 $3.64 Million - $4.26 Million	121,600 Added 47.04%	380,100 $12.8 Million
Q4 2023 Feb 13, 2024	SELL	$19.2 - $33.78 $645,120 - $1.14 Million	-33,600 Reduced 11.5%	258,500 $8.35 Million
Q3 2023 Nov 14, 2023	SELL	$31.89 - $39.03 $3.77 Million - $4.62 Million	-118,300 Reduced 28.83%	292,100 $9.57 Million
Q2 2023 Aug 11, 2023	SELL	$30.5 - $37.4 $1.69 Million - $2.07 Million	-55,400 Reduced 11.89%	410,400 $14.4 Million
Q1 2023 May 12, 2023	BUY	$30.8 - $53.92 $3.79 Million - $6.64 Million	123,100 Added 35.92%	465,800 $15.2 Million
Q4 2022 Feb 13, 2023	BUY	$45.4 - $60.91 $803,580 - $1.08 Million	17,700 Added 5.45%	342,700 $18.9 Million
Q3 2022 Nov 14, 2022	BUY	$42.06 - $55.45 $1.4 Million - $1.84 Million	33,200 Added 11.38%	325,000 $14.4 Million
Q2 2022 Aug 12, 2022	BUY	$33.54 - $52.15 $5.01 Million - $7.79 Million	149,300 Added 104.77%	291,800 $14.2 Million
Q1 2022 May 13, 2022	BUY	$33.14 - $51.13 $255,178 - $393,701	7,700 Added 5.71%	142,500 $6.93 Million
Q4 2021 Feb 11, 2022	BUY	$34.09 - $43.91 $3.25 Million - $4.19 Million	95,400 Added 242.13%	134,800 $5.75 Million
Q3 2021 Nov 12, 2021	BUY	$25.68 - $38.61 $708,768 - $1.07 Million	27,600 Added 233.9%	39,400 $1.51 Million
Q2 2021 Aug 13, 2021	BUY	$25.96 - $33.44 $306,328 - $394,592	11,800 New	11,800 $333,000

Others Institutions Holding HRMY

# of Institutions

288

Shares Held

46.3M

Call Options Held

130K

Put Options Held

46.5K

View Full List

About Harmony Biosciences Holdings, Inc.

Ticker HRMY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,161,400
Market Cap $2.1B
Description
Harmony Biosciences Holdings, Inc., a commercial-stage pharmaceutical company, develops and commercializes therapies for patients with rare neurological disorders in the United States. Its product, WAKIX is a medication for the treatment of excessive daytime sleepiness in adult patients with narcolepsy. The company was formerly known as Harmony ...

More about HRMY

Track Jim Simons's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Renaissance Technologies LLC, based on Form 13F filings with the SEC.

News

Stay updated on Renaissance Technologies LLC and Jim Simons with notifications on news.

Account